Safety, Feasibility, and Tolerability of Sulforaphane in Children With Chronic Kidney Disease
Status:
Not yet recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
This purpose of this study is to investigate potential new therapeutics in pediatric chronic
kidney disease (CKD). The specific aims are to identify safe dosing and tolerability of
sulforaphane (SFN) supplementation in children with moderate and advanced CKD. Secondary
objectives will include preliminary exploration of changes in oxidative and inflammatory
biomarkers in response to SFN supplementation in this population.